Two-Year Follow-Up after Endovenous Closure with Short-Chain Cyanoacrylate versus Laser Ablation in Venous Insufficiency

• Published in: Journal of clinical medicine 2021-02, Vol.10 (4), p.628
• Main Authors: Wilczko, Justyna, Szary, Cezary, Plucinska, Dominika, Grzela, Tomasz
• Format: Article
• Language: English
• Subjects: Ablation; Clinical medicine; Lasers; Patients; Sclerotherapy; Ultrasonic imaging; Viscosity
• ISSN: 2077-0383; 2077-0383
• DOI: 10.3390/jcm10040628

The current treatment of venous disease is focused on the minimally invasive exclusion of the affected vein. Besides widely used thermal ablation, chemical ablation with cyanoacrylate, reported as safe and highly effective, has been gaining increasing interest. In the current report, we present data from a two-year observation in 89 patients (61 female/28 male, mean age 44.3 ± 13.5) suffering from venous insufficiency (C2-C4), treated either using short-chain cyanoacrylate, the VenaBlock system ( = 43) or laser thermoablation with ELVeS 1470 ( = 46). The assessment comprised the occurrence of venous disease-related symptoms and the ultrasound examination of the leg venous system. The frequency of recanalization after 2 years from the VenaBlock procedure was significantly higher than after laser treatment (37.2 vs. 8.7%). Apart from recanalization, in some individuals from both groups, the symptoms of recurrence and/or disease progression, including the development of insufficiency in other veins of treated or contralateral legs (9.3 vs. 15.2% and 9.3 vs. 17.4%, respectively), were observed. Unexpectedly, the general prevalence of the disease progression did not differ significantly between the VenaBlock and ELVeS groups (44.2 vs. 34.8%, respectively). Despite the higher recanalization rate of VenaBlock compared to ELVeS, the overall effectiveness of cyanoacrylate and laser thermoablation after two years was similar. Therefore, both methods similarly failed to prevent recurrence and disease progression, which seem to be method-independent.